Trademark: ADVOCACY FOR IMPACT
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
ADVOCACY FOR IMPACT
Click here to search for trademarks similar to ADVOCACY FOR IMPACT
Proof of use for ADVOCACY FOR IMPACT
We do not have any records of a proof of use for ADVOCACY FOR IMPACT at this moment.
Possible trademark infringements of ADVOCACY FOR IMPACT
Basic Information about ADVOCACY FOR IMPACT
- Serial Number
- 88126473
- Filing Date
- 21 Sep 2018
- Registration Number
- 6603392
- Registration Date
- 28 Dec 2021
- Mark Drawing Code
- 4
Classifications
Declare the trademark use of ADVOCACY FOR IMPACT on the blockchain with WikiTrademarks.io.
- First use of ADVOCACY FOR IMPACT anywhere
- ADVOCACY FOR IMPACT was first used on 24 Oct 2018 for the primary classification of goods and services, international, 036 (Insurance and financial)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 036
- US Codes
- 100; 101; 102
Who owns ADVOCACY FOR IMPACT?
1. Alnylam Pharmaceuticals, Inc. Cambridge MA
2. Alnylam Pharmaceuticals, Inc. Cambridge MA
3. Alnylam Pharmaceuticals, Inc. Cambridge MA
Correspondent
- Sarah Anne Keefe
- Womble Bond Dickinson (US) LLP
- 470 Atlantic Avenue, Suite 600
- Boston MA 02210
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io